Cleared Traditional

K093305 - ENHANCED ULTRA VIT PROBE

K093305 is an FDA 510(k) clearance for ENHANCED ULTRA VIT PROBE, manufactured by Alcon Research, Ltd.. The device is a Class 2 Ophthalmic device with product code MLZ cleared through the Traditional 510(k) pathway after a 162-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2010
Decision
162d
Days
Class 2
Risk

K093305 is an FDA 510(k) clearance for the ENHANCED ULTRA VIT PROBE. Classified as Vitrectomy, Instrument Cutter (product code MLZ), Class II - Special Controls.

Submitted by Alcon Research, Ltd. (Irvine, US). The FDA issued a Cleared decision on April 2, 2010 after a review of 162 days - an extended review cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4150 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Alcon Research, Ltd. devices

FDA 510(k) Submission Details - K093305

510(k) Number K093305 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 22, 2009
Decision Date April 02, 2010
Days to Decision 162 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
52d slower than avg
Panel avg: 110d · This submission: 162d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MLZ Device Classification - Class 2, Special Controls

Product Code MLZ Vitrectomy, Instrument Cutter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4150
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.